Understanding ANA: Antinuclear Antibodies, Causes & Autoimmune Diseases

Antinuclear antibodies (ANA) are autoantibodies targeting nuclear components (DNA, histones, nucleoproteins, centromeres, etc.).

Significance

  • Screening test for systemic autoimmune diseases
  • Positive in: SLE (95–99%), Sjögren's, scleroderma, MCTD, polymyositis, autoimmune hepatitis
  • Also positive in: 5–15% healthy people (low titer), infections, medications, aging, cancer

Patterns Matter

  • Homogeneous (diffuse) — SLE, drug-induced lupus
  • Speckled — Sjögren's, scleroderma, MCTD
  • Centromere — limited scleroderma (CREST)
  • Nucleolar — diffuse scleroderma
  • Rim (peripheral) — SLE (anti-dsDNA)

Interpretation

  • Positive ANA ≠ disease — need clinical correlation
  • Titer and pattern guide further testing (anti-dsDNA, anti-Smith, anti-Scl-70, etc.)
  • Diagnosis requires clinical criteria + serology

Management

Treat underlying disease, not ANA. Rheumatology referral for positive ANA with symptoms.

Illness - Related Articles